115 related articles for article (PubMed ID: 9127150)
21. An altered peptide ligand specifically inhibits Th2 cytokine synthesis by abrogating TCR signaling.
Faith A; Akdis CA; Akdis M; Joss A; Wymann D; Blaser K
J Immunol; 1999 Feb; 162(3):1836-42. PubMed ID: 9973449
[TBL] [Abstract][Full Text] [Related]
22. Partial T cell signaling: altered phospho-zeta and lack of zap70 recruitment in APL-induced T cell anergy.
Sloan-Lancaster J; Shaw AS; Rothbard JB; Allen PM
Cell; 1994 Dec; 79(5):913-22. PubMed ID: 8001128
[TBL] [Abstract][Full Text] [Related]
23. The magnitude of TCR engagement is a critical predictor of T cell anergy or activation.
Mirshahidi S; Ferris LC; Sadegh-Nasseri S
J Immunol; 2004 May; 172(9):5346-55. PubMed ID: 15100274
[TBL] [Abstract][Full Text] [Related]
24. Persistence of peptide-induced CD4+ T cell anergy in vitro.
Ryan KR; Evavold BD
J Exp Med; 1998 Jan; 187(1):89-96. PubMed ID: 9419214
[TBL] [Abstract][Full Text] [Related]
25. Threshold signaling of human Th0 cells in activation and anergy: modulation of effector function by altered TCR ligand.
Verhoef A; Lamb JR
J Immunol; 2000 Jun; 164(11):6034-40. PubMed ID: 10820288
[TBL] [Abstract][Full Text] [Related]
26. Gene related to anergy in lymphocytes (GRAIL) expression in CD4+ T cells impairs actin cytoskeletal organization during T cell/antigen-presenting cell interactions.
Schartner JM; Simonson WT; Wernimont SA; Nettenstrom LM; Huttenlocher A; Seroogy CM
J Biol Chem; 2009 Dec; 284(50):34674-81. PubMed ID: 19833735
[TBL] [Abstract][Full Text] [Related]
27. Early growth response gene-2, a zinc-finger transcription factor, is required for full induction of clonal anergy in CD4+ T cells.
Harris JE; Bishop KD; Phillips NE; Mordes JP; Greiner DL; Rossini AA; Czech MP
J Immunol; 2004 Dec; 173(12):7331-8. PubMed ID: 15585857
[TBL] [Abstract][Full Text] [Related]
28. Prevention of T cell anergy by signaling through the gamma c chain of the IL-2 receptor.
Boussiotis VA; Barber DL; Nakarai T; Freeman GJ; Gribben JG; Bernstein GM; D'Andrea AD; Ritz J; Nadler LM
Science; 1994 Nov; 266(5187):1039-42. PubMed ID: 7973657
[TBL] [Abstract][Full Text] [Related]
29. Differential induction of the NF-AT complex during restimulation and the induction of T-cell anergy.
Wotton D; Higgins JA; O'Hehir RE; Lamb JR; Lake RA
Hum Immunol; 1995 Feb; 42(2):95-102. PubMed ID: 7744623
[TBL] [Abstract][Full Text] [Related]
30. Clonal anergy induced in a CD8+ hapten-specific cytotoxic T-cell clone by an altered hapten-peptide ligand.
Preckel T; Hellwig S; Pflugfelder U; Lappin MB; Weltzien HU
Immunology; 2001 Jan; 102(1):8-14. PubMed ID: 11168631
[TBL] [Abstract][Full Text] [Related]
31. Interleukin 2 production, not the pattern of early T-cell antigen receptor-dependent tyrosine phosphorylation, controls anergy induction by both agonists and partial agonists.
Madrenas J; Schwartz RH; Germain RN
Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9736-41. PubMed ID: 8790400
[TBL] [Abstract][Full Text] [Related]
32. Antigen presentation by T cells versus professional antigen-presenting cells (APC): differential consequences for T cell activation and subsequent T cell-APC interactions.
Taams LS; van Eden W; Wauben MH
Eur J Immunol; 1999 May; 29(5):1543-50. PubMed ID: 10359108
[TBL] [Abstract][Full Text] [Related]
33. Mannose-Capped Lipoarabinomannan from Mycobacterium tuberculosis Induces CD4+ T Cell Anergy via GRAIL.
Sande OJ; Karim AF; Li Q; Ding X; Harding CV; Rojas RE; Boom WH
J Immunol; 2016 Jan; 196(2):691-702. PubMed ID: 26667170
[TBL] [Abstract][Full Text] [Related]
34. Signalling events in the anergy induction of T helper 1 cells.
Sloan-Lancaster J; Allen PM
Ciba Found Symp; 1995; 195():189-96; discussion 196-202. PubMed ID: 8724838
[TBL] [Abstract][Full Text] [Related]
35. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells.
Sloan-Lancaster J; Evavold BD; Allen PM
Nature; 1993 May; 363(6425):156-9. PubMed ID: 8483498
[TBL] [Abstract][Full Text] [Related]
36. Molecular mechanisms of CD4+ T-cell anergy.
Fathman CG; Lineberry NB
Nat Rev Immunol; 2007 Aug; 7(8):599-609. PubMed ID: 17612584
[TBL] [Abstract][Full Text] [Related]
37. Regulation of cytokine production by human Th0 cells following stimulation with peptide analogues: differential expression of TGF-beta in activation and anergy.
Tsitoura DC; Gelder CM; Kemeny DM; Lamb JR
Immunology; 1997 Sep; 92(1):10-9. PubMed ID: 9370918
[TBL] [Abstract][Full Text] [Related]
38. Differential susceptibility of human T(h)1 versus T(h) 2 cells to induction of anergy and apoptosis by ECDI/antigen-coupled antigen-presenting cells.
Vandenbark AA; Barnes D; Finn T; Bourdette DN; Whitham R; Robey I; Kaleeba J; Bebo BF; Miller SD; Offner H; Chou YK
Int Immunol; 2000 Jan; 12(1):57-66. PubMed ID: 10607750
[TBL] [Abstract][Full Text] [Related]
39. Negative signaling contributes to T-cell anergy in trauma patients.
Bandyopadhyay G; De A; Laudanski K; Li F; Lentz C; Bankey P; Miller-Graziano C
Crit Care Med; 2007 Mar; 35(3):794-801. PubMed ID: 17255857
[TBL] [Abstract][Full Text] [Related]
40. Regulation of T-cell activation in the lung: alveolar macrophages induce reversible T-cell anergy in vitro associated with inhibition of interleukin-2 receptor signal transduction.
Strickland D; Kees UR; Holt PG
Immunology; 1996 Feb; 87(2):250-8. PubMed ID: 8698387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
